Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia.
Psychiatry Res
; 236: 179-181, 2016 Feb 28.
Article
en En
| MEDLINE
| ID: mdl-26774189
ABSTRACT
Inflammatory abnormalities have been shown in the pathogenesis of schizophrenia. Soluble urokinase-type plasminogen activator receptor (suPAR) is a protein that is measurable in the circulating blood and reflects the inflammation in the body. We aimed to investigate serum suPAR levels in patients with schizophrenia who were in acute state and to compare with healthy controls. Forty five patients and 43 healthy controls were included in the study. We found no significant difference in suPAR levels between patients and controls, suggesting that suPAR as an inflammatory marker does not have a role in the inflammatory process of acute schizophrenia.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Esquizofrenia
/
Receptores del Activador de Plasminógeno Tipo Uroquinasa
Tipo de estudio:
Observational_studies
Límite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Psychiatry Res
Año:
2016
Tipo del documento:
Article
Pais de publicación:
IE
/
IRELAND
/
IRLANDA